Poland Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2018

Publisher Name :
Date:31-Jan-2013
No. of pages: 158

“Poland Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2018″, a new report by Global Markets Direct, provides key market data on the Poland Ophthalmic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

  • Market size and company share data for Ophthalmic Devices market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the seven market categories.
  • Global corporate-level profiles of key companies operating within the Poland Ophthalmic Devicesmarket.
  • Key players covered include Essilor International, Carl Zeiss AG, Johnson & Johnson Vision Care, Inc., CIBA Vision Corporation, Alcon, Inc., Bausch & Lomb Incorporated and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Poland Ophthalmic Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Poland Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2018

Table of Contents

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 10

2 Introduction 13
2.1 What is This Report About? 13

3 Ophthalmic Devices In Poland 14
3.1 Ophthalmic Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 14
3.2 Ophthalmic Devices, Poland, Company Share (2010-2011) 20

4 Cataract Surgery Devices In Poland 22
4.1 Cataract Surgery Devices Overall Revenue, (2004-2018) 22
4.1.1 Ophthalmic Viscoelastic Devices (OVD), Revenue (2004-2018) 26
4.2 Cataract Surgery Devices Overall Volume (2004-2018) 30
4.2.1 Ophthalmic Viscoelastic Devices (OVD), Volume (2004-2018) 32
4.3 Cataract Surgery Devices Average Price (2004-2018) 34
4.4 Cataract Surgery Devices Distribution Share (2010-2011) 35
4.5 Cataract Surgery Devices, Poland, Company Share (2010-2011) 36

5 Glaucoma Surgery Devices In Poland 37
5.1 Glaucoma Surgery Devices Overall Revenue, (2004-2018) 37
5.2 Glaucoma Surgery Devices Overall Volume (2004-2018) 39
5.3 Glaucoma Surgery Devices Average Price (2004-2018) 41
5.4 Glaucoma Surgery Devices Distribution Share (2010-2011) 41
5.5 Glaucoma Surgery Devices, Poland, Company Share (2010-2011) 42

6 Intraocular Lens (IOL) In Poland 44
6.1 Intraocular Lens (IOL) Overall Revenue, (2004-2018) 44
6.1.1 Foldable IOL, Revenue, (2004-2018) 48
6.2 Intraocular Lens (IOL) Overall Volume (2004-2018) 52
6.2.1 Foldable IOL, Volume (2004-2018) 54
6.3 Intraocular Lens (IOL) Average Price (2004-2018) 56
6.4 Intraocular Lens (IOL) Distribution Share (2010-2011) 57
6.5 Intraocular Lens (IOL), Poland, Company Share (2010-2011) 58

7 Ophthalmic Diagnostic Equipment In Poland 59
7.1 Ophthalmic Diagnostic Equipment Overall Revenue, (2004-2018) 59
7.1.1 Retinal Ultrasound Imaging Systems, Revenue (2004-2018) 63
7.1.2 Ophthalmoscopes, Revenue (2004-2018) 67
7.2 Ophthalmic Diagnostic Equipment Overall Volume (2004-2018) 71
7.2.1 Retinal Ultrasound Imaging Systems, Volume (2004-2018) 75
7.2.2 Ophthalmoscopes, Volume (2004-2018) 77
7.3 Ophthalmic Diagnostic Equipment Average Price (2004-2018) 79
7.4 Ophthalmic Diagnostic Equipment Distribution Share (2010-2011) 81
7.5 Ophthalmic Diagnostic Equipment, Poland, Company Share (2010-2011) 82

8 Refractive Surgery Devices In Poland 84
8.1 Refractive Surgery Devices Overall Revenue, (2004-2018) 84
8.1.1 Ophthalmic Lasers, Revenue (2004-2018) 88
8.2 Refractive Surgery Devices Overall Volume (2004-2018) 92
8.2.1 Ophthalmic Lasers, Volume (2004-2018) 94
8.3 Refractive Surgery Devices Average Price (2004-2018) 96
8.4 Refractive Surgery Devices Distribution Share (2010-2011) 97
8.5 Refractive Surgery Devices, Poland, Company Share (2010-2011) 98

9 Vision Care In Poland 100
9.1 Vision Care Overall Revenue, (2004-2018) 100
9.1.1 Contact Lenses, Revenue (2004-2018) 102
9.1.2 Spectacle Lenses, Revenue (2004-2018) 106
9.1.3 Contact Lens Cleaning and Disinfecting Solutions, Revenue (2004-2018) 108
9.2 Vision Care Overall Volume (2004-2018) 110
9.2.1 Contact Lenses, Volume (2004-2018) 112
9.2.2 Spectacle Lenses, Volume (2004-2018) 114
9.2.3 Contact Lens Cleaning and Disinfecting Solutions, Volume (2004-2018) 116
9.3 Vision Care Average Price (2004-2018) 118
9.4 Vision Care Distribution Share (2010-2011) 120
9.5 Vision Care, Poland, Company Share (2010-2011) 121

10 Vitreo Retinal Surgery Devices In Poland 123
10.1 Vitreo Retinal Surgery Devices Overall Revenue, (2004-2018) 123
10.1.1 Vitreo Retinal Surgery Packs, Revenue (2004-2018) 127
10.2 Vitreo Retinal Surgery Devices Overall Volume (2004-2018) 131
10.2.1 Vitreo Retinal Surgery Packs, Volume (2004-2018) 133
10.3 Vitreo Retinal Surgery Devices Average Price (2004-2018) 135
10.4 Vitreo Retinal Surgery Devices Distribution Share (2010-2011) 136
10.5 Vitreo Retinal Surgery Devices, Poland, Company Share (2010-2011) 137

11 Overview of Key Companies in Poland Ophthalmic Devices Market 139
11.1 Essilor International 139
11.1.1 Company Overview 139
11.2 Carl Zeiss AG 139
11.2.1 Company Overview 139
11.3 Johnson & Johnson Vision Care, Inc. 139
11.3.1 Company Overview 139
11.4 CIBA Vision Corporation 140
11.4.1 Company Overview 140
11.5 Alcon, Inc. 140
11.5.1 Company Overview 140
11.6 Bausch & Lomb Incorporated 140
11.6.1 Company Overview 140
11.7 Hoya Corporation 141
11.7.1 Company Overview 141
11.8 CooperVision, Inc. 141
11.8.1 Company Overview 141
11.9 Abbott Medical Optics, Inc. 141
11.9.1 Company Overview 141
11.10 Sauflon Pharmaceuticals Limited 142
11.10.1 Company Overview 142
11.11 Seiko Optical Products Co., Ltd. 142
11.11.1 Company Overview 142
11.12 Topcon Corporation 142
11.12.1 Company Overview 142
11.13 Haag-Streit AG 143
11.13.1 Company Overview 143
11.14 SCHWIND eye-tech-solutions GmbH & Co. KG 143
11.14.1 Company Overview 143
11.15 Nidek Co., Ltd. 143
11.15.1 Company Overview 143
11.16 Ziemer Ophthalmic Systems AG 144
11.16.1 Company Overview 144
11.17 Heine Optotechnik GmbH & Co KG 144
11.17.1 Company Overview 144
11.18 Heidelberg Engineering GmbH 144
11.18.1 Company Overview 144
11.19 Ellex Medical Lasers Limited 145
11.19.1 Company Overview 145
11.20 Lumenis Ltd. 145
11.20.1 Company Overview 145
11.21 Tomey Corporation 145
11.21.1 Company Overview 145
11.22 New World Medical, Incorporated 146
11.22.1 Company Overview 146
11.23 iScience Interventional, Inc. 146
11.23.1 Company Overview 146
11.24 Molteno Ophthalmic Limited 146
11.24.1 Company Overview 146
11.25 Eagle Vision, Inc. 146
11.25.1 Company Overview 146

12 Appendix 147
12.1 Global Markets Direct Research Methodology 147
12.2 Definitions of Markets Covered in the Report 148
12.2.1 Ophthalmic Devices 148
12.3 Secondary Research 156
12.4 Primary Research 156
12.5 Models 157
12.6 Forecasts 157
12.7 Expert Panel Validation 157
12.8 Currency Conversion 158
12.9 Contact Us 158
12.10 Disclaimer 158

1.1 List of Tables

Table 1: Ophthalmic Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 15
Table 2: Ophthalmic Devices, Poland, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17
Table 3: Ophthalmic Devices, Poland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19
Table 4: Ophthalmic Devices, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 21
Table 5: Cataract Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 23
Table 6: Cataract Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 25
Table 7: Ophthalmic Viscoelastic Devices (OVD), Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 27
Table 8: Ophthalmic Viscoelastic Devices (OVD), Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 29
Table 9: Cataract Surgery Devices, Poland, Volume (Units) by Segment, Historic, 2004-2011 30
Table 10: Cataract Surgery Devices, Poland, Volume (Units) by Segment, Forecast, 2011-2018 31
Table 11: Ophthalmic Viscoelastic Devices (OVD), Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 32
Table 12: Ophthalmic Viscoelastic Devices (OVD), Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 33
Table 13: Cataract Surgery Devices, Poland, Average Price ($), Historic, 2004-2011 34
Table 14: Cataract Surgery Devices, Poland, Average Price ($), Forecast, 2011-2018 34
Table 15: Cataract Surgery Devices, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35
Table 16: Cataract Surgery Devices, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 36
Table 17: Glaucoma Surgery Devices, Poland, Revenue ($m) USD Constant, Historic, 2004-2011 37
Table 18: Glaucoma Surgery Devices, Poland, Revenue ($m) USD Constant, Forecast, 2011-2018 38
Table 19: Glaucoma Surgery Devices, Poland, Volume (Units), Historic, 2004-2011 39
Table 20: Glaucoma Surgery Devices, Poland, Volume (Units), Forecast, 2011-2018 40
Table 21: Glaucoma Surgery Devices, Poland, Average Price ($), Historic, 2004-2011 41
Table 22: Glaucoma Surgery Devices, Poland, Average Price ($), Forecast, 2011-2018 41
Table 23: Glaucoma Surgery Devices, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 41
Table 24: Glaucoma Surgery Devices, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 43
Table 25: Intraocular Lens (IOL), Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 45
Table 26: Intraocular Lens (IOL), Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 47
Table 27: Foldable IOL, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49
Table 28: Foldable IOL, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 51
Table 29: Intraocular Lens (IOL), Poland, Volume (Units) by Segment, Historic, 2004-2011 52
Table 30: Intraocular Lens (IOL), Poland, Volume (Units) by Segment, Forecast, 2011-2018 53
Table 31: Foldable IOL, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 54
Table 32: Foldable IOL, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 55
Table 33: Intraocular Lens (IOL), Poland, Average Price ($), Historic, 2004-2011 56
Table 34: Intraocular Lens (IOL), Poland, Average Price ($), Forecast, 2011-2018 56
Table 35: Intraocular Lens (IOL), Poland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 57
Table 36: Intraocular Lens (IOL), Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 58
Table 37: Ophthalmic Diagnostic Equipment, Poland, Revenue ($m*) USD Constant, by Segment, Historic, 2004-2011 60
Table 38: Ophthalmic Diagnostic Equipment, Poland, Revenue ($m*) USD Constant, by Segment, Forecast, 2011-2018 62
Table 39: Retinal Ultrasound Imaging Systems, Poland, Revenue ($m*) USD Constant, by Sub-Segment, Historic, 2004-2011 64
Table 40: Retinal Ultrasound Imaging Systems, Poland, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018 66
Table 41: Ophthalmoscopes, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 68
Table 42: Ophthalmoscopes, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 70
Table 43: Ophthalmic Diagnostic Equipment, Poland, Volume (Units) by Segment, Historic, 2004-2011 72
Table 44: Ophthalmic Diagnostic Equipment, Poland, Volume (Units) by Segment, Forecast, 2011-2018 74
Table 45: Retinal Ultrasound Imaging Systems, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 75
Table 46: Retinal Ultrasound Imaging Systems, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 76
Table 47: Ophthalmoscopes, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 77
Table 48: Ophthalmoscopes, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 78
Table 49: Ophthalmic Diagnostic Equipment, Poland, Average Price ($), Historic, 2004-2011 79
Table 50: Ophthalmic Diagnostic Equipment, Poland, Average Price ($), Forecast, 2011-2018 80
Table 51: Ophthalmic Diagnostic Equipment, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 81
Table 52: Ophthalmic Diagnostic Equipment, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 83
Table 53: Refractive Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 85
Table 54: Refractive Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 87
Table 55: Ophthalmic Lasers, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 89
Table 56: Ophthalmic Lasers, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 91
Table 57: Refractive Surgery Devices, Poland, Volume (Units) by Segment, Historic, 2004-2011 92
Table 58: Refractive Surgery Devices, Poland, Volume (Units) by Segment, Forecast, 2011-2018 93
Table 59: Ophthalmic Lasers, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 94
Table 60: Ophthalmic Lasers, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 95
Table 61: Refractive Surgery Devices, Poland, Average Price ($), Historic, 2004-2011 96
Table 62: Refractive Surgery Devices, Poland, Average Price ($), Forecast, 2011-2018 96
Table 63: Refractive Surgery Devices, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 97
Table 64: Refractive Surgery Devices, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 99
Table 65: Vision Care, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 100
Table 66: Vision Care, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 101
Table 67: Contact Lenses, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 103
Table 68: Contact Lenses, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 105
Table 69: Spectacle Lenses, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 106
Table 70: Spectacle Lenses, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 107
Table 71: Contact Lens Cleaning and Disinfecting Solutions, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 108
Table 72: Contact Lens Cleaning and Disinfecting Solutions, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 109
Table 73: Vision Care, Poland, Volume (Units) by Segment, Historic, 2004-2011 110
Table 74: Vision Care, Poland, Volume (Units) by Segment, Forecast, 2011-2018 111
Table 75: Contact Lenses, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 112
Table 76: Contact Lenses, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 113
Table 77: Spectacle Lenses, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 114
Table 78: Spectacle Lenses, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 115
Table 79: Contact Lens Cleaning and Disinfecting Solutions, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 116
Table 80: Contact Lens Cleaning and Disinfecting Solutions, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 117
Table 81: Vision Care, Poland, Average Price ($), Historic, 2004-2011 118
Table 82: Vision Care, Poland, Average Price ($), Forecast, 2011-2018 119
Table 83: Vision Care, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 120
Table 84: Vision Care, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 122
Table 85: Vitreo Retinal Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 124
Table 86: Vitreo Retinal Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 126
Table 87: Vitreo Retinal Surgery Packs, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 128
Table 88: Vitreo Retinal Surgery Packs, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 130
Table 89: Vitreo Retinal Surgery Devices, Poland, Volume (Units) by Segment, Historic, 2004-2011 131
Table 90: Vitreo Retinal Surgery Devices, Poland, Volume (Units) by Segment, Forecast, 2011-2018 132
Table 91: Vitreo Retinal Surgery Packs, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 133
Table 92: Vitreo Retinal Surgery Packs, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 134
Table 93: Vitreo Retinal Surgery Devices, Poland, Average Price ($), Historic, 2004-2011 135
Table 94: Vitreo Retinal Surgery Devices, Poland, Average Price ($), Forecast, 2011-2018 135
Table 95: Vitreo Retinal Surgery Devices, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 136
Table 96: Vitreo Retinal Surgery Devices, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 138

1.2 List of Figures

Figure 1: Ophthalmic Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 14
Figure 2: Ophthalmic Devices, Poland, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16
Figure 3: Ophthalmic Devices, Poland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 18
Figure 4: Ophthalmic Devices, Poland, Company Share (%), 2011 20
Figure 5: Cataract Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 22
Figure 6: Cataract Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 24
Figure 7: Ophthalmic Viscoelastic Devices (OVD), Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 26
Figure 8: Ophthalmic Viscoelastic Devices (OVD), Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 28
Figure 9: Cataract Surgery Devices, Poland, Volume (Units) by Segment, Historic, 2004-2011 30
Figure 10: Cataract Surgery Devices, Poland, Volume (Units) by Segment, Forecast, 2011-2018 31
Figure 11: Ophthalmic Viscoelastic Devices (OVD), Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 32
Figure 12: Ophthalmic Viscoelastic Devices (OVD), Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 33
Figure 13: Cataract Surgery Devices, Poland, Company Share (%), 2011 36
Figure 14: Glaucoma Surgery Devices, Poland, Revenue ($m) USD Constant, Historic, 2004-2011 37
Figure 15: Glaucoma Surgery Devices, Poland, Revenue ($m) USD Constant, Forecast, 2011-2018 38
Figure 16: Glaucoma Surgery Devices, Poland, Volume (Units), Historic, 2004-2011 39
Figure 17: Glaucoma Surgery Devices, Poland, Volume (Units), Forecast, 2011-2018 40
Figure 18: Glaucoma Surgery Devices, Poland, Company Share (%), 2011 42
Figure 19: Intraocular Lens (IOL), Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 44
Figure 20: Intraocular Lens (IOL), Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 46
Figure 21: Foldable IOL, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 48
Figure 22: Foldable IOL, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 50
Figure 23: Intraocular Lens (IOL), Poland, Volume (Units) by Segment, Historic, 2004-2011 52
Figure 24: Intraocular Lens (IOL), Poland, Volume (Units) by Segment, Forecast, 2011-2018 53
Figure 25: Foldable IOL, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 54
Figure 26: Foldable IOL, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 55
Figure 27: Intraocular Lens (IOL), Poland, Company Share (%), 2011 58
Figure 28: Ophthalmic Diagnostic Equipment, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 59
Figure 29: Ophthalmic Diagnostic Equipment, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 61
Figure 30: Retinal Ultrasound Imaging Systems, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 63
Figure 31: Retinal Ultrasound Imaging Systems, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 65
Figure 32: Ophthalmoscopes, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 67
Figure 33: Ophthalmoscopes, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 69
Figure 34: Ophthalmic Diagnostic Equipment, Poland, Volume (Units) by Segment, Historic, 2004-2011 71
Figure 35: Ophthalmic Diagnostic Equipment, Poland, Volume (Units) by Segment, Forecast, 2011-2018 73
Figure 36: Retinal Ultrasound Imaging Systems, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 75
Figure 37: Retinal Ultrasound Imaging Systems, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 76
Figure 38: Ophthalmoscopes, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 77
Figure 39: Ophthalmoscopes, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 78
Figure 40: Ophthalmic Diagnostic Equipment, Poland, Company Share (%), 2011 82
Figure 41: Refractive Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 84
Figure 42: Refractive Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 86
Figure 43: Ophthalmic Lasers, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 88
Figure 44: Ophthalmic Lasers, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 90
Figure 45: Refractive Surgery Devices, Poland, Volume (Units) by Segment, Historic, 2004-2011 92
Figure 46: Refractive Surgery Devices, Poland, Volume (Units) by Segment, Forecast, 2011-2018 93
Figure 47: Ophthalmic Lasers, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 94
Figure 48: Ophthalmic Lasers, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 95
Figure 49: Refractive Surgery Devices, Poland, Company Share (%), 2011 98
Figure 50: Vision Care, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 100
Figure 51: Vision Care, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 101
Figure 52: Contact Lenses, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 102
Figure 53: Contact Lenses, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 104
Figure 54: Spectacle Lenses, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 106
Figure 55: Spectacle Lenses, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 107
Figure 56: Contact Lens Cleaning and Disinfecting Solutions, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 108
Figure 57: Contact Lens Cleaning and Disinfecting Solutions, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 109
Figure 58: Vision Care, Poland, Volume (Units) by Segment, Historic, 2004-2011 110
Figure 59: Vision Care, Poland, Volume (Units) by Segment, Forecast, 2011-2018 111
Figure 60: Contact Lenses, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 112
Figure 61: Contact Lenses, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 113
Figure 62: Spectacle Lenses, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 114
Figure 63: Spectacle Lenses, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 115
Figure 64: Contact Lens Cleaning and Disinfecting Solutions, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 116
Figure 65: Contact Lens Cleaning and Disinfecting Solutions, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 117
Figure 66: Vision Care, Poland, Company Share (%), 2011 121
Figure 67: Vitreo Retinal Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 123
Figure 68: Vitreo Retinal Surgery Devices, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 125
Figure 69: Vitreo Retinal Surgery Packs, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 127
Figure 70: Vitreo Retinal Surgery Packs, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 129
Figure 71: Vitreo Retinal Surgery Devices, Poland, Volume (Units) by Segment, Historic, 2004-2011 131
Figure 72: Vitreo Retinal Surgery Devices, Poland, Volume (Units) by Segment, Forecast, 2011-2018 132
Figure 73: Vitreo Retinal Surgery Packs, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 133
Figure 74: Vitreo Retinal Surgery Packs, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 134
Figure 75: Vitreo Retinal Surgery Devices, Poland, Company Share (%), 2011 137
Figure 76: Global Markets Direct Methodology 147

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • 2014 Deep Research Report on Global and China Intravenous Catheter Industry
    Published: 22-Jul-2014        Price: US $2200 Onwards        Pages: 184
    This is a professional and depth research report on China Intravenous Catheter industry. The report firstly introduced Intravenous Catheter basic information included Intravenous Catheter definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Intravenous Catheter industry policy and plan, Intravenous Catheter product specification, man......
  • 2014 Deep Research Report on Global and China Particulate Respirators Industry
    Published: 19-Jul-2014        Price: US $2200 Onwards        Pages: 150
    This is a professional and depth research report on Global and China Particulate Respirators industry. The report firstly introduced Particulate Respirators basic information included Particulate Respirators definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Particulate Respirators industry policy and plan, Particulate Respirators product specif......
  • 2014 Deep Research Report on Global and China Sialic Acid Industry
    Published: 19-Jul-2014        Price: US $2200 Onwards        Pages: 136
    This is a professional and depth research report on Global and China Sialic Acid industry. The report firstly introduced Sialic Acid basic information included Sialic Acid definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Sialic Acid industry policy and plan, Sialic Acid product specification, manufacturing process, cost structure etc. then sta......
  • OpportunityAnalyzer: Dengue Vaccines – Opportunity Analysis and Forecasts to 2020
    Published: 17-Jul-2014        Price: US $5995 Onwards        Pages: 189
    Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, including fevers, retro-orbital pain, severe headache, muscle and joint pain, and rash. The severity of dengue fever ranges......
  • Greece Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 116
    BMI View: The Greek pharmaceutical and healthcare sector will continue contract over the medium-tolong term. Although Greece's financial outlook has stabilised and debts are being paid down, the government will continue to target the pharmaceutical and healthcare industry to reduce public spending. We highlight, however, that the generic drug sector and private healthcare industry will present some growth opportunities in the country. Headline Expenditure Projections ? Pharmaceuticals: EUR......
  • Lithuania Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 97
    BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 3.8%, rising to a value of LTL2.11bn (USD732mn) in 2018. The upcoming switch to the euro promises to boost purchasing power and stabilise the pharmaceutical market, albeit at the cost of increasing healthcare expenditure. Ceding control of monetary policy to Brussels leaves Lithuania with little leeway to increase its healthcare spending dramatically over the next five years. Th......
  • Moldova Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 96
    BMI View: BMI has upgraded its forecast for Moldova's pharmaceutical and healthcare market for 2014 due to improved economic conditions. Moldova is likely to sign the Association Agreement with the EU in June 2014, which would strengthen the business environment and improve the regulatory structure and access to the pharmaceutical market in the country. Moldova is undertaking a reform of its healthcare sector with the World Bank, which is likely to be positive for the sector. Any retaliatory......
  • Serbia Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 132
    The new Serbian government is actively trying to stabilise the country's fiscal position through cutting spending, encouraging outside investment and demand pickup for Serbian exports in order to reduce its debt burden. However, pharmaceutical spending is also a target for cuts. Local drug makers are set to feel the worst of these new measures as they cannot compete on cost compared to larger players in the market. The Serbian government has amended the Medicines Act with the specific aim of......
  • Slovakia Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 113
    BMI View: The Slovakian government is planning to allocate EUR278mn (USD386.7mn) in EU funding to develop healthcare and medical infrastructure in Slovakia over the 2014-2020 period, reports news agency TASR. The government added that after adding contributions from the state budget, the total funds that have been allocated for developing healthcare infrastructure will be EUR300mn (USD417.3mn). The government plans to allocate these funds to projects in large university hospitals and develop......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs